Issue navigation
Volume 191, Issue Supplement_1, July 2024
104th Annual Meeting of the British Association of Dermatologists
Foreword
Foreword
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Page iii, https://doi.org/10.1093/bjd/ljae090.fm001
Officers and Committee
Officers and Committee
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Page iv, https://doi.org/10.1093/bjd/ljae090.fm002
Clinical Vice President
Clinical Vice President
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Page v, https://doi.org/10.1093/bjd/ljae090.fm003
Guest Speakers
Guest Speakers
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Pages vi–viii, https://doi.org/10.1093/bjd/ljae090.fm004
Abstracts
Main Plenary Session
O01 Survey of Scottish Dermatology Society members on the new Medicines and Healthcare products Regulatory Agency isotretinoin recommendations
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Page i1, https://doi.org/10.1093/bjd/ljae090.001
O02 The effectiveness of adalimumab biosimilars and originator for the treatment of psoriasis: a cohort study from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR)
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Pages i1–i2, https://doi.org/10.1093/bjd/ljae090.002
O03 Comparing the treatment effectiveness and safety of ciclosporin, dupilumab and methotrexate in adult and paediatric patients with atopic eczema: results from the UK-Irish A-STAR register
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Pages i2–i3, https://doi.org/10.1093/bjd/ljae090.003
O04 How useful is chest X-ray in addition to routine QuantiFERON® in the detection of latent tuberculosis prior to biologics?
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Page i3, https://doi.org/10.1093/bjd/ljae090.004
O05 Risk of keratinocyte carcinomas in patients with psoriasis treated with biologic therapy: analysis from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR), on behalf of the BADBIR Study Group
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Pages i3–i4, https://doi.org/10.1093/bjd/ljae090.005
O06 Abatacept efficacy in severe refractory morphoea: experience from a specialized centre
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Page i4, https://doi.org/10.1093/bjd/ljae090.006
O07 Clinical and mycological profile of dermatophyte infections in England
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Pages i4–i5, https://doi.org/10.1093/bjd/ljae090.007
O08 Findings of the British Association of Dermatologist’s career survey of dermatologists in training and new consultant dermatologists
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Page i5, https://doi.org/10.1093/bjd/ljae090.008
O09 Cutaneous squamous cell carcinoma survival in England 2004–2020: a national retrospective observational cohort study
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Pages i5–i6, https://doi.org/10.1093/bjd/ljae090.009
O10 A national retrospective cohort study of the incidence and trends of 3061 cases of cutaneous T-cell lymphoma in England between 2013 and 2020
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Page i6, https://doi.org/10.1093/bjd/ljae090.010
O11 Associations between hyperlinearity of the sole and filaggrin variants in atopic eczema in a South Asian population: a cross-sectional study
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Pages i6–i7, https://doi.org/10.1093/bjd/ljae090.011
O12 Community Psoriasis: Phenotype and Comorbidity Assessment (COPPACA): an observational study of the prevalence, phenotype and health burden of psoriasis in the community
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Pages i7–i8, https://doi.org/10.1093/bjd/ljae090.012
O13 42 590 fewer skin tumours diagnosed in England during the 2020 COVID pandemic: greatest reductions in melanoma in situ, stage I melanomas and basal cell carcinomas
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Page i8, https://doi.org/10.1093/bjd/ljae090.013
Clinicopathological Cases
Clinicopathological CasesCPC01 An unexpected infection in dermatology outpatients: cutaneous diphtheria
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Page i8, https://doi.org/10.1093/bjd/ljae090.014
CPC02 Breast carcinoma presenting as carcinoma erysipeloides/en cuirasse of the left neck sparing the chest: a rare diagnostic challenge
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Pages i8–i9, https://doi.org/10.1093/bjd/ljae090.015
CPC03 Notch your average dermatitis
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Page i9, https://doi.org/10.1093/bjd/ljae090.016
CPC04 An atypical case of vasculitis: when immunosuppression is not the answer
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Pages i9–i10, https://doi.org/10.1093/bjd/ljae090.017
CPC05 A case of adult-onset en coup de sabre responsive to abatacept
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Page i10, https://doi.org/10.1093/bjd/ljae090.018
CPC06 The proof is in the ink: granulomatous tattoo reaction secondary to BRAF and MEK inhibition
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Pages i10–i11, https://doi.org/10.1093/bjd/ljae090.019
CPC07 Occupational cutaneous larva migrans presenting as diffuse folliculitis with concurrent helminthiasis
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Page i11, https://doi.org/10.1093/bjd/ljae090.020
CPC08 Two fatal cases of fulminant, rapidly progressive interstitial lung disease secondary to MDA5 dermatomyositis
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Pages i11–i12, https://doi.org/10.1093/bjd/ljae090.021
CPC09 Two cases of late-onset dystrophic epidermolysis bullosa COL7A1 mutations
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Page i12, https://doi.org/10.1093/bjd/ljae090.022
CPC10 A curious case of recurrent melanomas and field change confined to the left thigh over 25 years
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Pages i12–i13, https://doi.org/10.1093/bjd/ljae090.023
CPC11 A case of C3 bullous dermatosis
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Page i13, https://doi.org/10.1093/bjd/ljae090.024
CPC12 A metastatic melanoma mimic: malignant peripheral nerve sheath tumour in the setting of a rare germline BAP1 disease-causing variant
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Page i13, https://doi.org/10.1093/bjd/ljae090.025
CPC13 BRAF mutated and morphologically Spitz naevi and tumours: a series of four cases
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Pages i13–i14, https://doi.org/10.1093/bjd/ljae090.026
CPC14 Winning streak: a case of congenital ichthyosiform erythroderma
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Page i14, https://doi.org/10.1093/bjd/ljae090.027
Bristol Cup Posters
Bristol Cup PostersP001 A descriptive, observational and cross-sectional study of clinicoepidemiological, dermoscopic and histopathological aspects of primary localized cutaneous amyloidosis and its effect on the quality of life of the patient
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Pages i14–i15, https://doi.org/10.1093/bjd/ljae090.028
P002 Inflammatory vitiligo with raised borders: a rare case of pseudolymphoma mimicking hypopigmented mycosis fungoides
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Page i15, https://doi.org/10.1093/bjd/ljae090.029
P003 Papuloerythroderma of Ofuji-like eruption: unfolding a distinctive reactive pattern
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Pages i15–i16, https://doi.org/10.1093/bjd/ljae090.030
P004 Morphoea in a patient with clear cell renal cancer and lung metastases
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Page i16, https://doi.org/10.1093/bjd/ljae090.031
P005 Painful palmar papules: a rare variant of a familiar dermatosis
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Pages i16–i17, https://doi.org/10.1093/bjd/ljae090.032
P006 Tumour necrosis factor-α-induced lupus panniculitis: one case report and literature review
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Page i17, https://doi.org/10.1093/bjd/ljae090.033
P007 Secretory carcinoma arising from axillary accessory breast: a rare presentation
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Pages i17–i18, https://doi.org/10.1093/bjd/ljae090.034
P008 In over our heads?
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Page i18, https://doi.org/10.1093/bjd/ljae090.035
P009 Cylindrocarcinoma: a rare entity
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Pages i18–i19, https://doi.org/10.1093/bjd/ljae090.036
P010 Eosinophilic dermatosis of haematological malignancy mimicking insect bite-like reaction in a patient with chronic lymphocytic leukaemia: a case report
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Page i19, https://doi.org/10.1093/bjd/ljae090.037
P011 A case report of neonatal lupus erythematosus in a 3-month-old baby
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Page i19, https://doi.org/10.1093/bjd/ljae090.038
P012 A delayed diagnosis of neurofibromatosis type 1 during pregnancy
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Page i20, https://doi.org/10.1093/bjd/ljae090.039
P013 Eruptive seborrhoeic keratoses in late-onset constitutional mismatch repair deficiency
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Pages i20–i21, https://doi.org/10.1093/bjd/ljae090.040
P014 Eosinophilic dermatosis of haematological malignancy: a chronic relapsing pruritic condition
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Page i21, https://doi.org/10.1093/bjd/ljae090.041
P015 Acne: clues to the mechanism of disease
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Page i21, https://doi.org/10.1093/bjd/ljae090.042
P016 A case of poikilodermatous plaque-like haemangioma
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Page i22, https://doi.org/10.1093/bjd/ljae090.043
P017 Localized penile bullous pemphigoid: a case report
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Page i22, https://doi.org/10.1093/bjd/ljae090.044
P018 Puzzling vesicles: a clinicopathological challenge
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Pages i22–i23, https://doi.org/10.1093/bjd/ljae090.045
P019 Cutaneous amyloidoma: a rare variant of primary cutaneous marginal zone lymphoproliferative disorder
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Page i23, https://doi.org/10.1093/bjd/ljae090.046
P020 Lentigo maligna: a vanishing act
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Page i23, https://doi.org/10.1093/bjd/ljae090.047
P021 The diagnosis and management of pemphigus vegetans in pregnancy
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Pages i23–i24, https://doi.org/10.1093/bjd/ljae090.048
P022 A case of cutaneous plasmacytosis occurring in a patient with pulmonary adenocarcinoma
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Page i24, https://doi.org/10.1093/bjd/ljae090.049
P023 Real-world melanoma miss rate in an NHS hospital dermatology service
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Pages i24–i25, https://doi.org/10.1093/bjd/ljae090.050
P024 Skin cancer referrals by nonmedical practitioners: a prospective observational study
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Page i25, https://doi.org/10.1093/bjd/ljae090.051
P025 Community lesion imaging clinics for tele-triage of suspected skin cancer: implementation of a low-cost model in an NHS trust
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Pages i25–i26, https://doi.org/10.1093/bjd/ljae090.052
P026 Teledermatology from the other side: a clinical photographers’ perspective
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Page i26, https://doi.org/10.1093/bjd/ljae090.053
P027 Are skin cancer teaching ‘super clinics’ safe and effective? Results of a UK pilot study
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Page i26, https://doi.org/10.1093/bjd/ljae090.054
P028 The importance of clinical metadata when triaging patients for face-to-face assessment and possible biopsy in a teledermatology pathway
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Page i27, https://doi.org/10.1093/bjd/ljae090.055
P029 Targeted skin examinations: a reasonable compromise?
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Page i27, https://doi.org/10.1093/bjd/ljae090.056
P030 Implementing the Edmonton Obesity Staging System: a cross-sectional study of the prevalence and management of obesity in a systemic therapies clinic
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Pages i27–i28, https://doi.org/10.1093/bjd/ljae090.057
P031 Experience from a UK dermatology regional virtual biologics and high-cost drugs multidisciplinary team
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Page i28, https://doi.org/10.1093/bjd/ljae090.058
P032 Prevalence and severity of dermatological symptoms experienced after critical care admission: an observational study
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Pages i28–i29, https://doi.org/10.1093/bjd/ljae090.059
P033 Do suspected cancer pathway referrals to dermatology meet the NICE criteria for referral?
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Page i29, https://doi.org/10.1093/bjd/ljae090.060
P034 Using artificial intelligence to bridge the technical gap in dermatology: the role of large language models in creating an interactive Fitzpatrick skin phototype assessment
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Pages i29–i30, https://doi.org/10.1093/bjd/ljae090.061
P035 Quantifying the mutation burden of a therapeutic course of narrowband ultraviolet B (UVB) to help inform on the carcinogenicity of narrowband UVB
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Page i30, https://doi.org/10.1093/bjd/ljae090.062
P036 Dupilumab treatment normalizes skin barrier function in children aged 6–11 years with moderate-to-severe atopic dermatitis
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Page i30, https://doi.org/10.1093/bjd/ljae090.063
P037 Peripheral blood flow cytometry reveals heterogeneous but benign T-cell changes in patients with severe eczema undergoing dupilumab therapy
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Page i31, https://doi.org/10.1093/bjd/ljae090.064
P038 Impact of cumulative low-level ozone on keratinocytes and implications for atopic eczema pathogenesis
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Pages i31–i32, https://doi.org/10.1093/bjd/ljae090.065
P039 Human papillomavirus 8-associated skin field cancerization demonstrates signal transducer and activator of transcription 3 pathway activation: a novel therapeutic target
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Page i32, https://doi.org/10.1093/bjd/ljae090.066
P040 A prospective study to assess the association of serological markers (interleukins 17, 31 and 33) with disease severity and response to antihistamines in paediatric chronic spontaneous urticaria
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Pages i32–i33, https://doi.org/10.1093/bjd/ljae090.067
P041 The British Society for Dermatological Surgery’s national sustainable skin surgery audit standards and checklist: preliminary findings and recommendations from the first national audit
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Page i33, https://doi.org/10.1093/bjd/ljae090.068
P042 Developing a clinical audit methodology for monitoring dermatologist performance in artificial intelligence-enabled teledermatology pathways
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Pages i33–i34, https://doi.org/10.1093/bjd/ljae090.069
P043 Readability assessment of British Journal of Dermatology plain language summaries
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Page i34, https://doi.org/10.1093/bjd/ljae090.070
P044 Enabling skin research participation of under-represented ethnic minority populations: a codesigned inclusion toolkit
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Pages i34–i35, https://doi.org/10.1093/bjd/ljae090.071
P045 An international Delphi consensus to define a clinically appropriate definition of disease modification for plaque psoriasis
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Page i35, https://doi.org/10.1093/bjd/ljae090.072
P046 The hidden generic curriculum: identifying and formalizing important soft skills for trainee dermatologists. A retrospective review of journal club experience (2022–2023)
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Pages i35–i36, https://doi.org/10.1093/bjd/ljae090.073
P047 Dermatology Life Quality Index used as a standard in validation of 101 quality-of-life instruments: a systematic review
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Page i36, https://doi.org/10.1093/bjd/ljae090.074
P048 Immunosuppression and vaccination: a cross-specialty survey on current practices
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Pages i36–i37, https://doi.org/10.1093/bjd/ljae090.075
P049 Best foot forward: awareness of melanoma of the foot among podiatrists
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Page i37, https://doi.org/10.1093/bjd/ljae090.076
P050 Certificate of Eligibility for Specialist Registration (CESR) (portfolio pathway) satisfaction survey for dermatology trainees: a comparison of current CESR vs. national trainees, within a large UK teaching hospital
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Pages i37–i38, https://doi.org/10.1093/bjd/ljae090.077
P051 The what, how and why of basal cell carcinoma: natural progression and surgical intervention
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Page i38, https://doi.org/10.1093/bjd/ljae090.078
P052 How should we be identifying high-risk cutaneous squamous cell carcinoma in the UK? A dual-centre retrospective cohort study
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Pages i38–i39, https://doi.org/10.1093/bjd/ljae090.079
P053 Synchronous melanoma: a single-centre 5-year retrospective study
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Page i39, https://doi.org/10.1093/bjd/ljae090.080
P054 National incidence and survival of extramammary Paget disease 2013–2020 in England: reporting a total of 740 cases
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Pages i39–i40, https://doi.org/10.1093/bjd/ljae090.081
P055 A randomized single-blinded prospective study to compare simulated daylight photodynamic therapy with natural daylight photodynamic therapy for the treatment of multiple actinic keratoses
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Page i40, https://doi.org/10.1093/bjd/ljae090.082
P056 Reflectance confocal microscopy and basal cell carcinoma: is it time to embrace the new technology?
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Pages i40–i41, https://doi.org/10.1093/bjd/ljae090.083
P057 Primary squamous cell carcinoma of the scrotum: an analysis of the risk factors, histopathological characteristics and management of 10 patients managed at a specialist centre
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Page i41, https://doi.org/10.1093/bjd/ljae090.084
P058 Healthcare disparity affecting delayed diagnosis in acral lentiginous melanoma
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Page i41, https://doi.org/10.1093/bjd/ljae090.085
P059 Cutaneous sarcomas: a 5-year review of treatment outcomes and literature
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Page i42, https://doi.org/10.1093/bjd/ljae090.086
P060 An analysis of eye colour and iris pattern as a risk factor for skin cancer in immunosuppressed renal transplant recipients
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Page i42, https://doi.org/10.1093/bjd/ljae090.087
P061 Squamoid eccrine ductal carcinomas: challenges in diagnosis and management
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Pages i42–i43, https://doi.org/10.1093/bjd/ljae090.088
P062 A multicentre retrospective observational study reviewing the management of severely dysplastic naevi
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Page i43, https://doi.org/10.1093/bjd/ljae090.089
P063 Understanding the landscape of Kaposi sarcoma hospitalizations in the USA: demographic associations stratified by AIDS/HIV status
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Pages i43–i44, https://doi.org/10.1093/bjd/ljae090.090
P064 Prevention is better than cure: acitretin and chemoprevention
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Page i44, https://doi.org/10.1093/bjd/ljae090.091
P065 Attitudes and practices of patients with inflammatory bowel disease towards skin cancer risk and sun protection
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Pages i44–i45, https://doi.org/10.1093/bjd/ljae090.092
P066 Our journey to a successful NIHR grant application in dermatological surgery: the HEAL2 study protocol
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Page i45, https://doi.org/10.1093/bjd/ljae090.093
P067 A novel validated patient decision aid to enhance shared decision making for the management of actinic keratosis
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Pages i45–i46, https://doi.org/10.1093/bjd/ljae090.094
P068 A history of mycosis fungoides: from Alibert to mogamulizumab
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Page i46, https://doi.org/10.1093/bjd/ljae090.095
P069 Familial malignant melanoma: CDKN2A mutation-positive family tree
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Pages i46–i47, https://doi.org/10.1093/bjd/ljae090.096
P070 The epidemiology of skin cancer in Greater Manchester 2017–22: a retrospective cohort study using primary care records
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Page i47, https://doi.org/10.1093/bjd/ljae090.097
P071 Are Welsh primary schools sunproofed? Results of a national survey: sun protection practices in primary schools in Wales
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Pages i47–i48, https://doi.org/10.1093/bjd/ljae090.098
P072 Risk of incident cancer, excluding keratinocyte carcinoma, in patients with psoriasis treated with biologic therapy: a prospective cohort study from the British Association of Dermatologists Biologic and Immunomodulators Register (BADBIR), on behalf of the BADBIR Study Group
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Page i48, https://doi.org/10.1093/bjd/ljae090.099
P073 Prevalence, mortality and healthcare resource use for generalized pustular psoriasis compared with plaque psoriasis in England: a population-based cohort study
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Pages i48–i49, https://doi.org/10.1093/bjd/ljae090.100
P074 Milestone events in recessive dystrophic epidermolysis bullosa: findings from a prospective register study
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Page i49, https://doi.org/10.1093/bjd/ljae090.101
P075 A retrospective review of isotretinoin treatment-related psychosexual health side-effects in a tertiary dermatology clinic
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Pages i49–i50, https://doi.org/10.1093/bjd/ljae090.102
P076 Risk of psoriatic arthritis and uveitis among patients with psoriasis after COVID-19 infection: a nationwide cohort study
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Page i50, https://doi.org/10.1093/bjd/ljae090.103
P077 Toxic Epidermal Necrolysis-Optimal Management (TEN-OM): a retrospective cohort analysis from two centres
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Pages i50–i51, https://doi.org/10.1093/bjd/ljae090.104
P078 Establishing diagnostic criteria for vulval lichen sclerosus (SHELLS): an international electronic-Delphi consensus study
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Page i51, https://doi.org/10.1093/bjd/ljae090.105
P079 The lifetime risk of vitiligo across sociodemographic groups: a UK population-based cohort study
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Pages i51–i52, https://doi.org/10.1093/bjd/ljae090.106
P080 Bimekizumab efficacy and impact on pain in moderate-to-severe hidradenitis suppurativa: results from BE HEARD I and II
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Page i52, https://doi.org/10.1093/bjd/ljae090.107
P081 A highly selective Janus kinase 1 inhibitor, ivarmacitinib ointment, for the treatment of atopic dermatitis: results from a phase II study
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Pages i52–i53, https://doi.org/10.1093/bjd/ljae090.108
P082 Dupilumab is efficacious in patients above and below 60 years old with prurigo nodularis: pooled results from two phase III trials (LIBERTY-PN PRIME and PRIME2)
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Page i53, https://doi.org/10.1093/bjd/ljae090.109
P083 Ichthyosis vulgaris in a South Asian population with atopic eczema: prevalence, clinical phenotypes and filaggrin variants
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Pages i53–i54, https://doi.org/10.1093/bjd/ljae090.110
P084 The prevalence of inflammatory back pain in a secondary care psoriasis cohort
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Page i54, https://doi.org/10.1093/bjd/ljae090.111
P085 Efficacy and safety of 611 for the treatment of moderate-to-severe atopic dermatitis in adults
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Pages i54–i55, https://doi.org/10.1093/bjd/ljae090.112
P086 The UK-Irish Atopic Eczema Systemic TherApy Register (A-STAR): baseline characteristics of the cohort
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Pages i55–i56, https://doi.org/10.1093/bjd/ljae090.113
P087 The British Hair and Nail Society present a review of our national grand round of challenging hair disorders and the benefits to the wider British Association of Dermatologists membership
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Page i56, https://doi.org/10.1093/bjd/ljae090.114
P088 Physician-assessed effectiveness, patient-reported outcomes, and safety in adult and adolescent patients with atopic dermatitis treated with dupilumab: real-world insights 1 year into the GLOBOSTAD multinational prospective observational study
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Pages i56–i57, https://doi.org/10.1093/bjd/ljae090.115
P089 Counselling and monitoring for sexual dysfunction during treatment with isotretinoin: experience of Irish dermatologists
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Page i57, https://doi.org/10.1093/bjd/ljae090.116
P090 A randomized study to compare the efficacy of topical tofacitinib vs. topical tacrolimus in treatment of patients with unstable vitiligo
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Pages i57–i58, https://doi.org/10.1093/bjd/ljae090.117
P091 Surgical management of hidradenitis suppurativa: a 12-month review from a tertiary referral centre on the long-term outcomes of surgical intervention for groin, gluteal, perianal and genital disease
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Page i58, https://doi.org/10.1093/bjd/ljae090.118
P092 Bidirectional association between alopecia areata and herpes zoster: a nationwide population-based study
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Pages i58–i59, https://doi.org/10.1093/bjd/ljae090.119
P093 Bespoke omalizumab prescribing in chronic spontaneous urticaria
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Page i59, https://doi.org/10.1093/bjd/ljae090.120
P094 Oral tofacitinib monotherapy for the management of moderate-to-severe alopecia areata in children and adolescents: a retrospective analysis of 36 cases
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Pages i59–i60, https://doi.org/10.1093/bjd/ljae090.121
P095 Ten cases of scabies successfully treated with topical ivermectin
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Page i60, https://doi.org/10.1093/bjd/ljae090.122
P096 Deucravacitinib, an oral, selective, allosteric tyrosine kinase 2 (TYK2) inhibitor, in moderate-to-severe plaque psoriasis: safety profile in older (≥ 65 years) and younger (< 65 years) patients in the phase III POETYK PSO-1, PSO-2 and long-term extension trials
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Pages i60–i61, https://doi.org/10.1093/bjd/ljae090.123
P097 ‘Real-world’ Janus kinase inhibitor treatments in the UK-Irish A-STAR register: cohort profile and treatment outcomes
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Pages i61–i62, https://doi.org/10.1093/bjd/ljae090.124
P098 Association between air pollution and incidence of psoriasis: a nationwide population-based case–control study
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Page i62, https://doi.org/10.1093/bjd/ljae090.125
P099 Use of roflumilast in erosive oral inflammatory conditions
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Pages i62–i63, https://doi.org/10.1093/bjd/ljae090.126
P100 Critically appraised topic: is dupilumab a cause or a treatment for alopecia areata? A case series and literature review to guide discussions in clinical practice
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Page i63, https://doi.org/10.1093/bjd/ljae090.127
P101 Sustained improvement in atopic dermatitis disease control and treatment satisfaction with dupilumab in clinical practice: 4-year follow-up results from the RELIEVE-AD study
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Pages i63–i64, https://doi.org/10.1093/bjd/ljae090.128
P102 Cutaneous noninfectious manifestations of chronic granulomatous disease: a prospective study
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Page i64, https://doi.org/10.1093/bjd/ljae090.129
P103 Clinical clues for frontal fibrosing alopecia: a case series describing prominent, depressed forehead veins
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Pages i64–i65, https://doi.org/10.1093/bjd/ljae090.130
P104 Developing the Prospective Epidermolysis Bullosa Longitudinal Evaluation Study (PEBLES) to explore natural history and identify endpoints for the rare disease recessive dystrophic epidermolysis bullosa
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Page i65, https://doi.org/10.1093/bjd/ljae090.131
P105 Reporting of concomitant and rescue topical therapies in eczema randomized controlled trials evaluating a systemic treatment: a scoping review
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Pages i65–i66, https://doi.org/10.1093/bjd/ljae090.132
P106 Clinical outcomes and quality of life in a cross-sectional study of patients with moderate-to-severe psoriasis treated with bimekizumab in routine clinical practice
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Page i66, https://doi.org/10.1093/bjd/ljae090.133
P107 Updating the Assessment of the Psychological and Social Effects of Acne (APSEA) through factor analysis: developing the novel APSEA-3
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Pages i66–i67, https://doi.org/10.1093/bjd/ljae090.134
P108 Acne as an adverse effect of upadacitinib treatment for atopic dermatitis in adults and adolescents: a systematic review of short-term analysis
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Page i67, https://doi.org/10.1093/bjd/ljae090.135
P109 Association between air quality index and the risk of rosacea: a nationwide population-based cohort study
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Pages i67–i68, https://doi.org/10.1093/bjd/ljae090.136
P110 Comparative efficacy of low-dose oral minoxidil, topical minoxidil, and platelet-rich plasma with topical minoxidil in androgenetic alopecia: a randomized controlled trial
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Page i68, https://doi.org/10.1093/bjd/ljae090.137
P111 A retrospective analysis of cutaneous sarcoidosis
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Pages i68–i69, https://doi.org/10.1093/bjd/ljae090.138
P112 The British Hair and Nail Society present a review of our national grand round of challenging nail conditions and the benefits to the wider British Association of Dermatologists membership
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Page i69, https://doi.org/10.1093/bjd/ljae090.139
P113 Ocular involvement and care provision in children with epidermolysis bullosa
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Page i69, https://doi.org/10.1093/bjd/ljae090.140
British Cosmetic Dermatology Group
BC01 Evaluation of effectiveness of fractional ablative CO2 laser and triple combination cream in the treatment of melasma: a randomized controlled study
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Page i70, https://doi.org/10.1093/bjd/ljae090.141
BC02 Role of platelet-rich plasma in atrophic acne scars along with microneedling and subcision
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Page i70, https://doi.org/10.1093/bjd/ljae090.142
BC03 Assessment of atrophic and hypertrophic photoageing in patients with basal cell carcinoma
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Pages i70–i71, https://doi.org/10.1093/bjd/ljae090.143
Poster presentationsBC04 Clinical efficacy of oral tranexamic acid in lichen planus pigmentosus: case series
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Page i71, https://doi.org/10.1093/bjd/ljae090.144
BC05 Exploring perspectives on regulatory standards and ethical challenges in the nonsurgical facial aesthetics industry: a cross-sectional consensus survey
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Pages i71–i72, https://doi.org/10.1093/bjd/ljae090.145
BC06 A systematic review of social media and Melanotan, the ‘Barbie drug’
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Page i72, https://doi.org/10.1093/bjd/ljae090.146
